Gilead Sciences, Inc. · Foster City, CA United States
(NASDAQ: GILD)
| 333 Lakeside Dr. | Phone: 650-574-3000 |
| Foster City, CA | Fax: 650-578-9264 |
| 94404 | Toll Free: 800-445-3235 |
| United States |
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowGilead Sciences, Inc. Rankings
#299 in FORTUNE 500 (May 2011) | S&P 500 | #259 in FT Global 500 (June 2011) |
Company Description
Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes Truvada, a combination of two of its other drugs, Viread and Emtriva. It co-promotes another HIV treatment, called Atripla, in the US and Europe with Bristol-Myers Squibb. Other products on the market include AmBisome, used to treat systemic fungal infections such as those that accompany AIDS; Vistide, for AIDS-related eye infections; and hepatitis B antiviral Hepsera. Beyond HIV/AIDS, Gilead also markets Letairis, a treatment for pulmonary arterial hypertension and Cayston, an inhaled antibiotic for patients with cystic fibrosis.

Gilead Sciences, Inc. Reports

No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Top Gilead Sciences, Inc. Competitors